Literature DB >> 34538876

Rapid Profiling of Chemical Constituents in Qingfei Paidu Granules Using High Performance Liquid Chromatography Coupled with Q Exactive Mass Spectrometry.

Shuai Fu1, Rongrong Cheng1, Zilei Xiang1, Zixin Deng1,2, Tiangang Liu1,2,3.   

Abstract

Qingfei Paidu (QFPD) granules have played a critical role during the Coronavirus Disease 2019 (COVID-19) in China. However, worldwide acceptance has been a problem because of the complex ingredients and unique theory of treatment. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-mass spectrometry (MS) and the Orbitrap traditional Chinese medicine library (OTCML) were used to investigate the chemical constituents of QFPD granules. By comparing retention times, masses, isotope ion patterns, and MS2 profiles, 108 compounds were putatively identified using the OTCML combined with manual verification, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. Of these compounds, 17 were confirmed using reference standards. In addition, representative compounds of these different chemical types were used as examples to analyze the fragmentation pathways and characteristic product ions. Moreover, 20 herbs within the QFPD granules were also identified to establish the sources of these chemical components. This is the first rapid profiling of the chemical constituents of QFPD granules using HPLC-Q Exactive Orbitrap-MS and yields valuable information for further quality control and mechanistic studies of QFPD granules. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10337-021-04085-0.
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.

Entities:  

Keywords:  Chemical constituent identification; HPLC-Q Exactive Orbitrap-MS; Orbitrap traditional Chinese medicine library; Qingfei Paidu granules

Year:  2021        PMID: 34538876      PMCID: PMC8435196          DOI: 10.1007/s10337-021-04085-0

Source DB:  PubMed          Journal:  Chromatographia        ISSN: 0009-5893            Impact factor:   2.044


Introduction

Qingfei Paidu (QFPD) granules and decoctions are effective traditional Chinese medicines (TCMs) that are included in the Guidelines for Diagnosis and Treatment of COVID-19 Pneumonia, issued by the National Heath Commission of the People’s Republic of China [1]. QFPD granules and decoctions are based on the following four formulae: Maxing-Shigan-Tang, Wuling-San, Xiaocaihu-Tang, and Shegan-Mahuang-Tang [2], which are different forms of prescription QFPD. QFPD granules contain 20 herbs: Ephedrae Herba, Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle, Armeniacae Semen Amarum, Cinnamomi Ramulus, Pogostemonis Herba, Alismatis Rhizoma, Polyporus, Atractylodis Macrocephalae Rhizoma, Poria, Bupleuri Radix, Scutellariae Radix, Pinelliae Rhizoma Praeparatum Cum Zingibere Et Alumine, Zingiberis Rhizoma Recens, Asteris Radix Et Rhizoma, Farfarae Flos, Belamcandae Rhizoma, Asari Radix Et Rhizoma, Dioscoreae Rhizoma, Aurantii Fructus Immaturus, and Citri Reticulatae Pericarpium. In addition, QFPD contains the mineral Gypsum Fibrosum. In China, QFPD granules and decoctions have been widely used to treat patients infected with SARS-CoV-2 owing to positive treatment results. Early treatment with prescription QFPD was associated with favorable patient outcomes and may be an effective strategy for epidemic control [1]. Functional network pharmacology analysis units showed that QFPD protected against COVID-19 through anti-viral and anti-inflammatory activities [2]. A systematic pharmacological study illustrated that QFPD exhibited immune regulation, anti-infection and anti-inflammatory properties, and multi-organ protection [3]. QFPD granules were, therefore, approved for market use by the National Medical Products Administration in China [4]. However, worldwide acceptance of QFPD granules is challenging because of the TCM complexity, and unique theory of treatment, in addition to quality and safety issues [5, 6]. Thus, comprehensive identification of the chemical components of QFPD granules is extremely critical for quality control, in addition to identification of the active ingredients and investigation of the mechanism-of-action. Few analytical strategies have been applied to study the chemical constituents of QFPD decoctions, and no detailed analysis of the chemical composition of QFPD granules has been reported [7-9]. Hybrid quadrupole-Orbitrap mass spectrometry (MS) is a powerful tool for structure elucidation of TCMs due to its high resolution and high-quality MS2 fragmentation patterns. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-MS was used to analyze the chemical constituents of QFPD granules, with 108 compounds putatively identified, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. The individual herbs within the QFPD granules were also analyzed. The aim of this study is to develop an analytical method for elucidating the chemical constituents of QFPD granules and provide valuable quality control and mechanism-of-action data.

Material and Methods

Reagents and Materials

QFPD granules were a gift from Renmin Hospital of Wuhan University. The 21 raw materials were purchased from Yifeng Pharmacy Chain Co., Ltd. (Changde, China). Acetonitrile (HPLC grade) and methanol (HPLC grade) were purchased from Merck (Darmstadt, Germany). Formic acid was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Watsons distilled water was obtained from Jingdong Mall (Beijing, China). Authentic standards of cytosine, sucrose, citric acid, uridine, adenosine, 2-pyrrolidinecarboxylic acid, and guanosine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Nicotinic acid was obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Nicotinamide and tangeretin were purchased from Shanghai Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China). Salicylic acid was acquired from Ascender Chemical Co., Ltd. (Shanghai, China). Glycyrrhizic acid, 18-β-glycyrrhetinic acid, isoliquiritigenin, baicalin, and narirutin were purchased from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China). Chlorogenic acid was a gift from Thermo Fisher Scientific.

Standard Solutions and Sample Preparations

The QFPD granules were ground, and the resultant powder (0.4 g) was accurately weighed, dissolved in 60% methanol (v/v; 20 mL), and sonicated for 30 min, resulting in partial precipitation of the QFPD granules. The solution was centrifuged, and the supernatant was filtered through a 0.22 μm membrane prior to HPLC-Q Exactive Orbitrap-MS. The individual raw materials were treated using the same procedure. The authentic standards were dissolved in 50% methanol and stored at – 80 ℃. Prior to qualitative analysis, they were mixed appropriate concentrations and filtered using a 0.22 μm membrane.

HPLC-Q Exactive Hybrid Quadrupole-Orbitrap MS

LC–MS was performed using an UltiMate 3000 UPLC system (Thermo Fisher Scientific), autosampler, a vacuum degasser, binary pump, and column compartment. A Hypersil Gold aQ C18 column (2.1 × 150 mm, 3 μm) was used at 40 ℃ for chromatography. The mobile phase consisted of acetonitrile/0.1% formic acid (A) and water/0.1% formic acid (B) at a flow rate of 0.2 mL/min. The following gradient elution program was used: 0–2 min, 0–5% (A); 2–42 min, 5–95% (A); 42–46.9 min, 95% (A); 46.9–47 min, 95–5% (A); 47–50 min, 5% (A). The total run time was 50 min, and the sample injection volume was 5 μL. A Q Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) with heated electrospray ionization (ESI) was used. Source parameters were optimized with a spray voltage of 3.5 kV ( +)/3.2 kV (−). The other parameters were set as follows: capillary temperature, 320 ℃; auxiliary gas temperature, 350 ℃; sheath gas, 40 Arb; auxiliary gas, 15 Arb; sweep gas, 0 Arb; S-lens RF level, 50. The Orbitrap mass detector was operated in full scan plus data-dependent MS2 mode. The MS resolution was set at 70,000 for the full scan and 17,500 for the MS2 scan. The automatic gain control target and maximum injection time were 1 × 106 ions capacity and 100 ms, respectively. The top N (N: the number of most abundant ions for fragmentation) was five, while the scan range was m/z 100–1500. The normalized collision energies were 20%, 40%, and 60%, and the isolation window was 1.2 Da. The apex trigger was 5–15 s, and the loop count was 3. The dynamic exclusion was 5 s.

Data Analysis Using the Orbitrap Traditional Chinese Medicine Library (OTCML) and Manual Verification

The raw data were imported into the Compound Discoverer (CD) software, which is integrated into the OTCML. The molecular masses, retention times, fragments, and peak areas from both the positive and negative ESI modes were compared to the mzVault library, which was integrated into CD. The mzVault spectral library (Thermo Fisher Scientific) contained the retention times, precise mass ions, and MS2 fragments of 1200 commercial reference standards, which were analyzed using Q Exactive Orbitrap-MS. The software identified peaks with high mass accuracy (< 10 ppm) and an isotope pattern variation within 85%. The molecular compositions adhered to the H/C ratio rules and were matched to potential compounds using ring and double-bond equivalents. The MS2 profiles were compared with the reference spectra from the mzVault library. Compounds were identified only when the match score was > 85. In addition, compound identification accuracy was improved by comparing the obtained data and possible fragmentation patterns with those in the literature, and the corresponding individual herb pieces components were analyzed to determine the source of each compound and elucidate chemical compositions.

Results and discussion

Positive and negative ion modes were used to detect the chemical compounds within the QFPD granules. The base peak chromatograms (BPCs) of the QFPD granules are shown in Fig. 1. In total, 108 compounds are putatively identified (Table 1). The BPCs of the individual herb pieces are shown in Figs. S1 and S2. Compound identification is summarized below.
Fig. 1

Base peak chromatograms of QFPD granules obtained using high performance liquid chromatography- Q Exactive hybrid quadrupole-Orbitrap mass spectrometry. A Electrospray ionization in the positive mode (ESI( +)), B electrospray ionization in the negative mode (ESI( −))

Table 1

Identification of the chemical components of QFPD granules using high performance liquid chromatography-Q Exactive hybrid quadrupole-Orbitrap mass spectrometry combined with the Orbitrap traditional Chinese medicine library

No.RT (min)FormulaPotential compoundDetected m/zCharacterized MS2Compound classHerbRefs
1d2.11C12H22O11Sucrose341.1069 [M – H]

89.0235

71.1031

59.0132b

MiscellaneousPR[10]
2d2.12C5H9NO22-Pyrrolidinecarboxylic acid116.0709 [M + H]+

116.0708

70.0658b

MiscellaneousDR[11]
3d2.12C4H5N3OCytosine112.0508 [M + H]+

112.0508b

95.0244

AlkaloidsAR
42.13C5H11NO2Betaine118.0865 [M + H]+

118.0864b

59.0737

AlkaloidsAE
52.14C7H7NO2Trigonelline138.0550 [M + H]+

138.0550b

110.0603

94.0656

AlkaloidsPC[12]
6d2.2C6H8O7Citric acid191.0185 [M – H]

111.0078b

87.0079

MiscellaneousGR
7d2.66C6H5NO2Nicotinic acid124.0395 [M + H]+

124.0394b

96.0448

80.05

Alkaloids
8acd2.69C9H12N2O6Uridine243.0608 [M – H]

200.0554

152.0339

122.0234

110.0238b

MiscellaneousPR[13]
9d2.69C6H6N2ONicotinamide123.0555 [M + H]+

123.0554b

96.0448

80.0501

AlkaloidsFF
10ad2.73C10H13N5O4Adenosine268.1041 [M + H]+136.0618bMiscellaneousPC[14]
11acd2.87C10H13N5O5Guanosine284.0989 [M + H]+152.0567bMiscellaneousPC[14]
123.41C7H6O5Gallic acid169.013 [M – H]

125.0233b

97.0285

69.0337

Phenolic acids
133.9C9H11NO2l-Phenylalanine166.0863[M + H]+

120.0809b

103.0546

Miscellaneous
144.22C6H6O35-Hydroxymethylfurfural127.0392 [M + H]+

109.0288b

81.0341

MiscellaneousPC[15]
154.68C9H13NOl-norephedrine152.1069 [M + H]+

134.0965b

117.0701

AlkaloidsEH[16]
165.12C9H13NOd-norpseudoephedrine152.1069 [M + H]+

134.0965b

117.0701

AlkaloidsEH[16]
175.24C15H14O7( −)-Gallocatechin305.0651 [M – H]

219.0654

137.0232

125.0232b

Phenols
185.32C7H6O4Protocatechuic acid153.0181 [M – H]109.0284bPhenolic acidsGR[15]
196.09C10H15NOl-ephedrine166.1226 [M + H]+

148.1120b

133.0887

117.0701

91.0547

AlkaloidsEH[16]
206.47C10H15NOd-pseudoephedrine166.1226 [M + H]+

148.1120b

133.0887

117.0701

91.0547

AlkaloidsEH[16]
216.99C11H17NOMethylephedrine180.1382 [M + H]+

162.1276b

147.1041

135.0805

117.0701

AlkaloidsEH[16]
227.26C7H6O3Protocatechualdehyde137.0233 [M – H]

137.0233b

119.0126

109.0285

PhenolsCR[15]
23c9.16C20H27NO11Amygdalin456.1492 [M – H]

323.0963

221.0653

161.0443

59.0132b

MiscellaneousAS[17]
24 cd9.43C16H18O9Chlorogenic acid353.0862 [M – H]

191.0548b

135.0441

179.0337

PhenylpropanoidsFF[18]
259.46C9H6O4Esculetin177.0181 [M – H]

177.0180b

149.0236

133.0284

105.0336

Phenylpropanoids
269.48C7H6O2p-Hydroxybenzaldehyde121.0285 [M – H]

121.0284b

93.0336

Phenols
279.78C9H8O4Caffeic acid179.0337 [M – H]135.0441bPhenolic acids
28a10.49C15H14O6Catechin hydrate289.0703 [M – H]

245.0805

123.044

109.0284b

Flavonoids
29a10.63C15H12O7Taxifolin303.0494 [M – H]

177.018

125.0233b

FlavonoidsSR[19]
30c10.98C27H30O15Vicenin II593.1482 [M – H]

353.0648b

383.0753

473.1062

297.075

FlavonoidsGR[8]
3111.12C25H24O121,3-Dicaffeoylquinic acid515.1168 [M – H]

353.0859

191.0547b

179.0336

135.044

Phenylpropanoids
3211.87C9H8O3p-Coumaric acid163.0400 [M – H]

119.0496b

163.0394

Phenylpropanoids
33ac11.95C26H28O14Isoschaftoside563.1376 [M – H]

353.0648b

383.0754

473.1073

FlavonoidsGR[20]
3411.96C9H10O43,5-Dimethoxy-4-hydroxybenzaldehyde183.0652 [M + H]+

140.0469

123.0443

95.0497b

Phenols

CR

EH

RE

[15]
3512.18C21H20O11Orientin447.0913 [M – H]

357.06

327.0496b

299.0541

133.028

AlkaloidsCP[21]
3612.6C10H8O4Scopoletin193.0497 [M + H]+

193.0496b

178.026

133.0285

PhenylpropanoidsAF[22]
37ac12.7C26H30O13Naringenin 7-O-(2-β-d-apiofuranosyl)-β-d-glucopyranoside549.1588 [M – H]

255.0649

135.0077

119.0492b

FlavonoidsGR[20]
3812.84C10H10O4Ferulic acid193.0492 [M – H]

178.0258

134.0362b

Phenylpropanoids
3913.03C11H10O5Isofraxidin223.0601 [M + H]+

223.0601b

190.0261

162.0311

Phenylpropanoids
40c13.04C27H32O15Eriocitrin595.1638 [M – H]

459.1152

151.0025b

135.0441

Flavonoids

CP

AF

[21]

[23]

41c13.04C26H30O13Liquiritin apioside549.1586 [M – H]

119.0491b

135.0077

255.0649

FlavonoidsGR[20]
42c13.18C27H30O16Rutin609.1431[M – H]

300.0258b

271.0234

255.0284

Flavonoids
4313.39C9H6O45,7-Dihydroxychromone177.0180 [M – H]

177.0180b

135.0076

Flavonoids
44d13.75C7H6O3Salicylic acid137.0233 [M – H]

137.0233

93.0337b

Phenolic acidsAE[15]
4513.8C14H12O4Piceatannol243.0648 [M – H]

243.0648b

201.0544

159.0439

Phenols
4613.84C25H24O12Isochlorogenic acid B515.1165 [M – H]

353.0856

191.0547

179.0336

135.0440b

PhenylpropanoidsFF[18]
47 cd13.89C27H32O14Narirutin581.1863 [M + H]+

273.0755b

153.0181

85.0289

71.0498

FlavonoidsCP[21]
48a14.02C29H36O15Verbascoside623.1945 [M – H]

461.1639

161.0231b

133.0283

PhenylpropanoidsPH[15]
4914.13C25H24O123,5-Dicaffeoylquinic acid515.1165 [M – H]

353.0878

191.0558b

179.0346

135.0448

PhenylpropanoidsFF[18]
5014.14C22H22O11Tectoridin463.1234 [M + H]+

301.0705b

286.047

FlavonoidsBH

[24]

[25]

51ac14.27C27H32O14Naringin579.1688 [M – H]

271.0597

151.0025b

119.0491

107.0129

Flavonoids

AF

CP

[23]

[21]

5214.57C9H16O4Azelaic acid187.0962[M – H]

125.0960b

97.0649

Miscellaneous
5314.62C28H34O15Neohesperidin609.1796 [M – H]

609.1791

301.0700b

286.0466

FlavonoidsCP
5414.95C25H24O12Isochlorogenic acid C515.1166 [M – H]

353.088

191.0558

173.0452

135.0448b

PhenylpropanoidsFF[18]
55c15C28H34O15Hesperidin609.1796 [M – H]

609.1791

301.0699b

286.0466

FlavonoidsCP[26]
5615.06C24H26O13Iridin523.1445 [M + H]+

361.0915b

346.0679

331.0445

FlavonoidsBH[25]
5715.06C9H6O2Coumarin147.0440 [M + H]+

147.0440b

103.0546

91.0547

Phenylpropanoids

CR

EH

[15]
58a15.63C15H12O6Eriodictyol287.0547 [M – H]

287.0547

161.0231

125.0233b

FlavonoidsAF[23]
59c15.86C26H30O13Isoliquiritin apioside549.1589 [M – H]

255.0649

153.0181

135.0077

119.0491b

FlavonoidsGR[20]
6016.06C22H22O9Ononin431.1336 [M + H]+

269.0807b

254.0573

237.0544

FlavonoidsGR[27]
61 cd16.08C21H18O11Baicalin445.0753 [M – H]269.0439bFlavonoidsSR[19]
6216.15C21H20O10Oroxin A433.1129 [M + H]+

271.0599b

253.0493

123.0078

FlavonoidsSR[19]
63a16.23C21H22O9Isoliquiritin419.1334 [M + H]+

257.0806b

147.0439

137.0232

FlavonoidsGR[20]
64c16.51C15H12O4Liquiritigenin255.0651 [M – H]

135.0078

119.0492b

91.0181

FlavonoidsGR[20]
6516.87C11H6O4Bergaptol201.0180 [M – H]

201.0192b

183.1012

139.1117

Phenylpropanoids
66c16.92C21H18O11Norwogonin-8-glucuronide445.0753 [M – H]269.0441bFlavonoidsSR[19]
6717.2C28H34O14Poncirin593.1842 [M – H]

593.184

285.0753b

151.0024

FlavonoidsAF[23]
6817.24C21H18O11Norwogonin-7-glucuronide445.0752 [M – H]269.0439bFlavonoidsSR[19]
69c17.51C22H20O11Oroxylin A-7-O-β-d-glucuronide459.0910 [M – H]

283.0595

268.0362b

FlavonoidsSR[19]
70c18.11C21H18O11Baicalein-6-glucuronide445.0754 [M – H]269.0441bFlavonoidsSR[19]
71c18.14C22H20O11Wogonoside459.0909 [M – H]

283.0595

268.0362b

FlavonoidsSR[19]
7218.58C15H12O5Naringenin chalcone273.0756 [M + H]+

273.0757

153.0182b

147.044

119.0493

Flavonoids

GR

AF

CP

[20]

[23]

[21]

73c19.32C16H14O6Hesperetin301.0702 [M – H]

301.0702b

286.044

164.0103

108.0207

FlavonoidsCP[26]
7419.38C16H12O6Tectorigenin299.0546[M – H]

284.0301b

240.0414

Flavonoids
75ac20.01C18H16O8Irigenin359.0756 [M – H]

344.0519

329.0286b

314.0054

286.0104

FlavonoidsBH[24]
7620.03C16H12O7Isorhamnetin315.0496 [M – H]

315.0496

300.0260b

271.0237

151.002

FlavonoidsAE[28]
77c20.15C17H14O7Iristectorigenin B329.0652 [M – H]

314.0417

299.0180b

271.0235

FlavonoidsBH[24]
7820.39C15H10O5Baicalein269.0443 [M – H]

269.0457b

241.0507

223.0398

FlavonoidsSR[19]
79 cd20.97C15H12O4Isoliquiritigenin255.0650 [M – H]

135.0076

119.0491b

91.018

FlavonoidsGR[20]
8021.08C16H12O4Formononetin269.0807 [M + H]+

269.0807b

254.0574

FlavonoidsGR[20]
81ac21.35C15H16O4Isomeranzin261.1119 [M + H]+

189.0546b

159.0439

131.0492

Phenylpropanoids
82ac21.65C42H62O17Licorice-saponin G2837.3869 [M – H]

837.386

351.0552

193.0341

113.0235b

TerpenoidsGR[20]
83c21.83C26H30O8Limonin469.1846 [M – H]

469.1831b

249.0909

229.1214

TerpenoidsAF[22]
8421.83C15H22O2Curcumenol235.1693 [M + H]+

235.169

217.1588

199.1482b

Terpenoids
8522.15C20H20O7Isosinensetin373.1283 [M + H]+

373.1281b

343.0812

FlavonoidsCP[26]
86 cd22.64C30H46O418 β-Glycyrrhetinic acid471.3469 [M + H]+

417.3471b

453.3362

TerpenoidsGR[29]
87 cd22.65C42H62O16Glycyrrhizic acid821.3926 [M – H]

821.3915b

351.056

113.0234

TerpenoidsGR[20]
8822.72C20H18O8Irisflorentin387.1073 [M + H]+

387.1073b

372.0843

357.0603

329.0654

FlavonoidsBH[25]
8922.84C20H20O7Sinensetin373.1282 [M + H]+

373.1281b

343.0809

FlavonoidsCP[26]
9022.98C18H14O8Dichotomitin359.0762 [M + H]+

359.0761b

344.0526

326.0421

299.0549

FlavonoidsBH[24]
91a23.16C16H12O5Wogonin285.0757 [M + H]+

285.0756

270.0521b

FlavonoidsSR[19]
9223.34C42H62O16isomer of Glycyrrhizic acid821.3922 [M – H]

821.3919b

351.0551

113.0235

TerpenoidsGR
93c23.57C42H68O13Saikosaponin A825.4599 [M + COOH]

779.4534b

617.40106

59.0132

TerpenoidsBR[26]
9423.91C17H14O6Pectolinarigenin313.0703 [M – H]

313.0701

283.0233b

255.0286

FlavonoidsSR[19]
9523.99C21H22O8Nobiletin403.1388 [M + H]+

403.1388

373.0917b

211.0238

183.0288

FlavonoidsCP[26]
96a24.04C19H18O66-Demethoxytangeretin343.1174 [M + H]+

343.1173

313.0705b

285.0756

FlavonoidsCP[26]
97c24.09C42H68O13Saikosaponin B1825.4599 [M + COOH]

779.4542b

617.4028

59.0132

TerpenoidsBR
98a24.13C16H12O5Oroxylin A285.0758 [M + H]+

285.0757

270.0523b

168.0054

FlavonoidsSR[19]
9924.21C15H20O3Atractylenolide III249.1486 [M + H]+

231.1379b

249.1481

213.1276

163.0752

TerpenoidsAM[30]
10024.49C22H24O9Heptamethoxyflavone433.1493 [M + H]+

403.1021

433.1492b

165.0546

FlavonoidsCP[26]
101c24.7C42H68O13Saikosaponin D825.4594 [M + COOH]

779.4537b

617.4034

59.0132

TerpenoidsBR
102d25.67C20H20O7Tangeretin373.1280 [M + H]+

373.1278

358.1043

343.0808b

328.0573

FlavonoidsCP[26]
10326.41C20H20O85-O-Demethylnobiletin389.1230 [M + H]+

389.1227b

359.076

341.0652

FlavonoidsCP[21]
10426.68C32H48O6Alisol C 23-acetate529.3526 [M + H]+

529.3521b

469.3314

451.3204

415.2842

TerpenoidsAR[31]
10527.85C15H20O2Atractylenolide II233.1536 [M + H]+

233.1536b

215.1432

187.1482

151.0753

TerpenoidsAM[30]
10627.94C12H16O4Pogostone225.1122 [M + H]+

207.1015

139.039

81.0705b

MiscellaneousPH[32]
10734.7C32H50O5Alisol B 23-acetate515.3733 [M + H]+

437.3412

339.2679

419.3305

97.0653b

TerpenoidsAR[31]
10835.79C18H30O2α-Linolenic acid279.2318 [M + H]+

95.086

81.0705

67.055b

Alkaloids

RT retention time

aRepresentative retention time, as more than one peak was identified for this compound

bBase fragment ion

cCompounds detected using both the positive and negative electrospray ionization modes. m/z: mass-to-charge ratio

dCompounds identified by comparison with reference standards. Herb: Compound detected within herb experimentally and also the reference reported the source of the compound. Ref.: The references that reported the sources of the compounds. EH (Ephedrae Herba), GR (Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle), AS (Armeniacae Semen Amarum), CR (Cinnamomi Ramulus), PH (Pogostemonis Herba), AR (Alismatis Rhizoma), PP (Polyporus), AM (Atractylodis Macrocephalae Rhizoma), PR (Poria), BR (Bupleuri Radix), SR (Scutellariae Radix); PC (Pinelliae Rhizoma Praeparatum Cum Zingibere Et Alumine), ZR (Zingiberis Rhizoma Recens), AE (Asteris Radix Et Rhizoma), FF (Farfarae Flos), BH (Belamcandae Rhizoma), RE (Asari Radix Et Rhizoma), DR (Dioscoreae Rhizoma), AF (Aurantii Fructus Immaturus); CP (Citri Reticulatae Pericarpium)

Base peak chromatograms of QFPD granules obtained using high performance liquid chromatography- Q Exactive hybrid quadrupole-Orbitrap mass spectrometry. A Electrospray ionization in the positive mode (ESI( +)), B electrospray ionization in the negative mode (ESI( −)) Identification of the chemical components of QFPD granules using high performance liquid chromatography-Q Exactive hybrid quadrupole-Orbitrap mass spectrometry combined with the Orbitrap traditional Chinese medicine library 89.0235 71.1031 59.0132b 116.0708 70.0658b 112.0508b 95.0244 118.0864b 59.0737 138.0550b 110.0603 94.0656 111.0078b 87.0079 124.0394b 96.0448 80.05 200.0554 152.0339 122.0234 110.0238b 123.0554b 96.0448 80.0501 125.0233b 97.0285 69.0337 120.0809b 103.0546 109.0288b 81.0341 134.0965b 117.0701 134.0965b 117.0701 219.0654 137.0232 125.0232b 148.1120b 133.0887 117.0701 91.0547 148.1120b 133.0887 117.0701 91.0547 162.1276b 147.1041 135.0805 117.0701 137.0233b 119.0126 109.0285 323.0963 221.0653 161.0443 59.0132b 191.0548b 135.0441 179.0337 177.0180b 149.0236 133.0284 105.0336 121.0284b 93.0336 245.0805 123.044 109.0284b 177.018 125.0233b 353.0648b 383.0753 473.1062 297.075 353.0859 191.0547b 179.0336 135.044 119.0496b 163.0394 353.0648b 383.0754 473.1073 140.0469 123.0443 95.0497b CR EH RE 357.06 327.0496b 299.0541 133.028 193.0496b 178.026 133.0285 255.0649 135.0077 119.0492b 178.0258 134.0362b 223.0601b 190.0261 162.0311 459.1152 151.0025b 135.0441 CP AF [21] [23] 119.0491b 135.0077 255.0649 300.0258b 271.0234 255.0284 177.0180b 135.0076 137.0233 93.0337b 243.0648b 201.0544 159.0439 353.0856 191.0547 179.0336 135.0440b 273.0755b 153.0181 85.0289 71.0498 461.1639 161.0231b 133.0283 353.0878 191.0558b 179.0346 135.0448 301.0705b 286.047 [24] [25] 271.0597 151.0025b 119.0491 107.0129 AF CP [23] [21] 125.0960b 97.0649 609.1791 301.0700b 286.0466 353.088 191.0558 173.0452 135.0448b 609.1791 301.0699b 286.0466 361.0915b 346.0679 331.0445 147.0440b 103.0546 91.0547 CR EH 287.0547 161.0231 125.0233b 255.0649 153.0181 135.0077 119.0491b 269.0807b 254.0573 237.0544 271.0599b 253.0493 123.0078 257.0806b 147.0439 137.0232 135.0078 119.0492b 91.0181 201.0192b 183.1012 139.1117 593.184 285.0753b 151.0024 283.0595 268.0362b 283.0595 268.0362b 273.0757 153.0182b 147.044 119.0493 GR AF CP [20] [23] [21] 301.0702b 286.044 164.0103 108.0207 284.0301b 240.0414 344.0519 329.0286b 314.0054 286.0104 315.0496 300.0260b 271.0237 151.002 314.0417 299.0180b 271.0235 269.0457b 241.0507 223.0398 135.0076 119.0491b 91.018 269.0807b 254.0574 189.0546b 159.0439 131.0492 837.386 351.0552 193.0341 113.0235b 469.1831b 249.0909 229.1214 235.169 217.1588 199.1482b 373.1281b 343.0812 417.3471b 453.3362 821.3915b 351.056 113.0234 387.1073b 372.0843 357.0603 329.0654 373.1281b 343.0809 359.0761b 344.0526 326.0421 299.0549 285.0756 270.0521b 821.3919b 351.0551 113.0235 779.4534b 617.40106 59.0132 313.0701 283.0233b 255.0286 403.1388 373.0917b 211.0238 183.0288 343.1173 313.0705b 285.0756 779.4542b 617.4028 59.0132 285.0757 270.0523b 168.0054 231.1379b 249.1481 213.1276 163.0752 403.1021 433.1492b 165.0546 779.4537b 617.4034 59.0132 373.1278 358.1043 343.0808b 328.0573 389.1227b 359.076 341.0652 529.3521b 469.3314 451.3204 415.2842 233.1536b 215.1432 187.1482 151.0753 207.1015 139.039 81.0705b 437.3412 339.2679 419.3305 97.0653b 95.086 81.0705 67.055b RT retention time aRepresentative retention time, as more than one peak was identified for this compound bBase fragment ion cCompounds detected using both the positive and negative electrospray ionization modes. m/z: mass-to-charge ratio dCompounds identified by comparison with reference standards. Herb: Compound detected within herb experimentally and also the reference reported the source of the compound. Ref.: The references that reported the sources of the compounds. EH (Ephedrae Herba), GR (Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle), AS (Armeniacae Semen Amarum), CR (Cinnamomi Ramulus), PH (Pogostemonis Herba), AR (Alismatis Rhizoma), PP (Polyporus), AM (Atractylodis Macrocephalae Rhizoma), PR (Poria), BR (Bupleuri Radix), SR (Scutellariae Radix); PC (Pinelliae Rhizoma Praeparatum Cum Zingibere Et Alumine), ZR (Zingiberis Rhizoma Recens), AE (Asteris Radix Et Rhizoma), FF (Farfarae Flos), BH (Belamcandae Rhizoma), RE (Asari Radix Et Rhizoma), DR (Dioscoreae Rhizoma), AF (Aurantii Fructus Immaturus); CP (Citri Reticulatae Pericarpium)

Alkaloids

Twelve alkaloids were detected. Compounds 19, 20, 21, 15, and 16 are observed in the positive BPC of QFPD, with no matching identification results after data processing using the OTCML. The mass spectra of compounds 15, 19, and 21 display the same fragment ions at m/z 117.0701 (Fig. S3). The mass spectra of compounds 19 and 20 exhibit the same [M + H]+ ions at m/z 166.1226 (C10H15NO), with the same fragment ions also observed at m/z 148.1120 [M + H – H2O]+ and 133.0887 [M + H – H2O – CH3]+. According to the literature [16], they are identified as L-ephedrine (19) and D-pseudoephedrine (20). The mass spectrum of compound 21 (methylephedrine) reveals a peak representing the protonated molecule [M + H]+, at m/z 180.1382, and fragment ion peaks at m/z 162.1276 [M + H – H2O]+ and 147.1041 [M + H – H2O – CH3]+. The mass spectra of compounds 15 (l-norephedrine) and 16 (D-norpseudoephedrine) reveal the same peak at m/z 152.1069, and MS2 peaks at m/z 134.0965 [M + H – H2O]+ and 117.0701 [M + H – H2O – NH3]+. However, they exhibit different retention times. These compounds are phytochemicals present in Ephedrae Herba. Compounds 3 (cytosine), 7 (nicotinic acid), and 9 (nicotinamide) were identified by comparing the retention times and MS2 fragmentation patterns with those of reference standards. Nicotinic acid and nicotinamide exhibit the same structural skeleton, and fragment ion peaks at m/z 96.0448 [M + H – CO]+ are observed in the MS2 profiles. Their possible fragmentation pathways and library match results are shown in Fig. S4. The MS2 profile of compound 5 reveals a peak representing a protonated molecule, [M + H]+, at m/z 138.0550 and peaks at m/z 110.0603 [M + H − CO]+ and 94.0656 [M + H − CO − O]+. Therefore, compound 5 is deduced to be trigonelline.

Flavonoids

Forty-nine compounds were identified as flavonoids. Compounds 47 and 51 were identified as narirutin and naringin, respectively, by comparison with the OTCML. Furthermore, compound 47 was confirmed using a reference standard. They were detected in both the positive and negative ESI modes, displaying similar MS and MS2 profiles that revealed peaks representing [M − H]− ions at m/z 579.1688. Fragment ions were represented by peaks at m/z 271.0615, owing to the loss of glucose (Glc) and rhamnose moieties [21]. Characterized fragment ions represented by peaks at m/z 151.0034 and 119.0499 were generated by retro-Diels–Alder cleavage. Narirutin and naringin are flavonoid O-glycoside isomers distinguished by their different retention times. Compounds 87 (isosinensetin), 89 (sinensetin), 96 (6-demethoxytangeretin), 95 (nobiletin), and 102 (tangeretin) are polymethoxyflavones, bearing numerous methoxyl and/or hydroxyl groups on the basic structure. The mass spectra of these compounds show peaks representing [M + H]+ ions and characterized fragment ions due to continuous CH3 loss [26]. The MS2 profiles and library match results are shown in Fig. S5. As examples, the mass spectra of compounds 85 and 89 reveal peaks representing [M + H]+ ions at m/z 373.1283 and characterized fragment ions at m/z 343.08 [M + H − 2CH3]+. The spectra are very similar, and the compounds were identified using the OTCML by the different retention times and slight differences in the spectra. Compound 102 (tangeretin) was further confirmed using a reference standard. Compounds 30 and 33 showed similar MS2 patterns, but the molecular ions were different, indicating the same basic structure. These compounds were assigned as vicenin II [8] and isoschaftoside [20, 33], respectively. For example, the mass spectrum of compound 30 revealed peaks representing the [M − H]− ion at m/z 593.1482 and fragment ions at m/z 297.0750 [M − H − Glc − Glc]−, m/z 473.1062 [M − H − 120]−, m/z 383.0753 [M – H – 210]−, and m/z 353.0648 [M − H − 240]−. These are characterized fragment ions of the hexose ring-opening reaction [33]. The similarities of the MS and MS2 profiles of compounds 37, 41, and 59 indicated isomers. By comparing the data in the OTCML combined with literature data [20], they were deduced as naringenin 7-O-(2-β-d-apiofuranosyl)-β-d-glucopyranoside (37), liquiritin apioside (41), and isoliquiritin apioside (59). The mass spectra of compounds 61, 68, 66, and 70 revealed peaks representing [M − H]− ions at m/z 445.07 and dominant fragment ions at m/z 269.04, along with [M + H]+ ions at m/z 447.09 and dominant fragment ions at m/z 271.05. Individual herb pieces component mass spectra showed that these compounds, baicalin (61), norwogonin-7-glucuronide (68), norwogonin-8-glucuronide (66) and baicalein-6-glucuronide (70), were chemical components of Scutellariae Radix [19], and baicalin (61) was identified using a reference standard. Based on the literature [26], compounds 73 and 100 were assigned as hesperetin and heptamethoxyflavone, respectively. Compound 79 (isoliquiritigenin) was identified using a reference standard.

Phenylpropanoids

Fourteen compounds were identified as phenylpropanoids. Compounds 31 (1,3-dicaffeoylquinic acid), 46 (isochlorogenic acid B), 49 (3,5-dicaffeoylquinic acid) and 53 (isochlorogenic acid C) were identified using the OTCML. Compound 24 (chlorogenic acid) was identified using a reference standard. Compounds 31, 46, 49 and 53 were isomers with skeletons similar to those of quinic and caffeic acid, generating similar MS and MS2 profiles and distinguished by their retention times. For example, the MS2 profile of compound 46 revealed peaks representing fragment ions at m/z 191.0547 [quinic acid − H]−, 179.0336 [caffeic acid − H]− and 135.0440 [caffeic acid − CO2 − H]−. The mass spectrum of compound 38 (ferulic acid) showed peaks representing a [M – H]− ion at m/z 193.0492 and the main fragment ions at m/z 134.0362 [M − H − CH3 − CO2]− and 178.0258 [M − H − CH3]−. Compounds 32 (p-coumaric acid), 57 (coumarin), 65 (bergaptol) and 25 (esculetin) were assigned using the OTCML.

Phenolic Acids and Phenols

Four phenolic acids were identified, and they exhibited the same fragmentation pattern. The MS2 profile of compound 12 (gallic acid) revealed peaks representing [M − H]− at m/z 169.0130 and ions at m/z 125.0233 [M − H − CO2]−, 97.0285 [M − H − CO2 − CO]− and 69.0337 [M − H − CO2 − CO − CO]−. The mass spectrum of compound 18 (protocatechuic acid) revealed a peak representing a base fragment ion at m/z 109.0284 [M − H − CO2]−. Compound 44 (salicylic acid) was identified by comparison with a reference standard. All of these compounds exhibited successive losses of H2O, CO and CO2 during fragmentation [34, 35]. Five phenols were identified. Compound 26 (p-hydroxybenzaldehyde) produced several clear fragment ions at high collision energies. Compound 22 (protocatechualdehyde) was identified using the OTCML. The phenols also showed neutral losses of CO, CH3 and H2O in the MS2 profiles.

Terpenoids

Thirteen terpenoids are identified. The mass spectra of compounds 82 and 87 reveal peaks representing [M + H]+ ions at m/z 839.4061 and 823.4108, respectively. The mass spectrum of compound 82 (licorice-saponin G2) reveals peaks representing fragment ions at m/z 469.3314 [Aglycone + H − H2O]+, 487.3412 [Aglycone + H]+ and 451.3212 [Aglycone + H − 2H2O]+ [36]. Compound 87 displays a similar fragmentation pattern, yet is 16 Da smaller than compound 82. Compound 87 was then confirmed as glycyrrhizic acid through a comparison between the negative ESI mode data, a reference standard, and literature data [20]. These spectra are shown in Fig.S6. The mass spectrum of compound 86, 18 β-glycyrrhetinic acid, reveals a peak representing [M + H]+ at m/z 471.3469. These are triterpenic acids. Compound 86 (18 β-glycyrrhetinic acid) was also identified using a reference standard. The MS2 profile of compound 104 showed peaks representing a protonated molecule, [M + H]+, at m/z 529.3526 and dominant fragment ions at m/z 529.3521 [M + H]+, 469.3314 [M + H − HAc]+, 451.3204 [M + H – HAc − H2O]+ and 415.2842 [M + H − C4H8O − H2O]+ [31]. This compound was identified as alisol C 23-acetate using the OTCML. The mass spectrum of compound 107, alisol B 23-acetate, revealed a peak representing [M + H]+ at m/z 515.3733. The mass spectrum of compound 93 revealed peaks representing a [M + H]+ ion at m/z 781.4732 and fragment ions at m/z 455.3518 [M + H − H2O − Fuc (fucose) Glc]+ and 437.3412 [M + H − 2H2O − FucGlc]+. This compound was identified as saikosaponin A by comparison with data obtained from the OTCML. The mass spectrum of compound 83 exhibited peaks representing [M + H]+ at m/z 471.2016 and fragment ions at m/z 425.1957 [M + H − 46]+ and 161.0597. According to the literature [23] and the data in the OTCML, it was limonin. The mass spectra of compounds 99 and 105 revealed peaks representing [M + H]+ ions at m/z 249.1486 and 233.1536, respectively. They were identified as atractylenolide III and atractylenolide II, respectively, using the OTCML. The MS2 profile of atractylenolide III revealed peaks representing fragment ions at m/z 249.1481 [M + H]+, 231.1379 [M + H − H2O]+, 213.1276 [M + H − 2H2O]+ and 203.1430 [M + H − H2O − CO]+ [30].

Other Phytochemicals

Eleven compounds were identified by comparing the obtained data to the information in the OTCML, including the hydrophilic compounds 1 (sucrose), 2 (2-pyrrolidinecarboxylic acid), 6 (citric acid), 8 (uridine), 10 (adenosine) and 11 (guanosine). These compounds were also confirmed using reference standards.

Quantification Analysis

The extracted ion chromatograms (EICs) of 17 authentic standards compared with those of their corresponding detected compounds within QFPD granules are shown in Fig. 2. The HPLC-Q Exactive hybrid quadrupole-Orbitrap MS method was also used for quantification analysis of these 17 constituents within QFPD granules. The concentration of each constituent was obtained using the respective calibration curve and their contents within the QFPD granules are listed in Table 2.
Fig. 2

Extracted ion chromatograms (EICs) of 17 authentic standards compared with those of the corresponding compounds detected within QFPD granules. A EICs of compounds 3, 11, and 24; B EICs of compounds 7, 44, and 9; C EICs of compounds 8, 86, and 79; D EICs of compounds 1, 102, and 47; E EICs of compounds 2, 6, and 61; F EICs of compounds 10 and 87. R sample from the QFPD granules, S authentic standards

Table 2

Contents of the constituents within QFPD granules

NoCompoundConc.(mg/g)
1Sucrose0.683 ± 0.185
22-Pyrrolidinecarboxylic acid0.803 ± 0.017
3Cytosine0.009 ± 0.0008
6Citric acid4.309 ± 0.352
7Nicotinic acid0.011 ± 0.0007
8Uridine0.029 ± 0.005
9Nicotinamide0.006 ± 0.0003
10Adenosine0.164 ± 0.009
11Guanosine0.135 ± 0.004
24Chlorogenic acid0.854 ± 0.015
44Salicylic acid0.016 ± 0.002
47Narirutin0.699 ± 0.119
61Baicalin4.383 ± 1.107
79Isoliquiritigenin0.007 ± 0.00005
8618 β-Glycyrrhetinic Acid0.0005 ± 0.000007
87Glycyrrhizic acid2.199 ± 0.127
102Tangeretin0.003 ± 0.0003

Data present the (average ± standard deviation) of three replicates. Conc. (mg/g): mg of the constituent/ g of QFPD granules

Extracted ion chromatograms (EICs) of 17 authentic standards compared with those of the corresponding compounds detected within QFPD granules. A EICs of compounds 3, 11, and 24; B EICs of compounds 7, 44, and 9; C EICs of compounds 8, 86, and 79; D EICs of compounds 1, 102, and 47; E EICs of compounds 2, 6, and 61; F EICs of compounds 10 and 87. R sample from the QFPD granules, S authentic standards Contents of the constituents within QFPD granules Data present the (average ± standard deviation) of three replicates. Conc. (mg/g): mg of the constituent/ g of QFPD granules

Compounds from Individual Herbs Within QFPD Granules

In total, 265 compounds were putatively identified using the OTCML combined with manual verification from 20 herbs that are components of QFPD granules (Table S1), including 33 alkaloids, 106 flavonoids, 28 terpenoids, 41 phenylpropanoids, 10 phenolic acids, 18 phenols and 29 other phytochemicals. Of these, 163 compounds were from only one herb, and 102 compounds were from more than two herbs. Within the QFPD granules, 59 compounds were from only one herb and 49 compounds were from more than two herbs.

Conclusions

In this study, HPLC-Q Exactive hybrid quadrupole-Orbitrap MS coupled with the OTCML which is an automatic data analysis platform, was used to study the chemical profile of QFPD granules, an effective TCM prescribed to treat the symptoms of SARS-CoV-2 infections. Furthermore, manual verification ensured compound identification. A total of 108 compounds were putatively identified from QFPD granules, including alkaloids, flavonoids, phenylpropanoids, phenolic acids, phenols, terpenoids and other phytochemicals. This allowed rapid chemical composition screening of QFPD granules, providing potentially valuable information for quality control and further clinical application. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 2553 kb)
  27 in total

1.  PREPARATIVE ISOLATION AND PURIFICATION OF FIVE FLAVONOIDS FROM POGOSTEMON CABLIN BENTH BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY AND PREPARATIVE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.

Authors:  Kang Li; Hongwu Zhang; Huichun Xie; Yong Liang; Xiaohong Wang; Yoichiro Ito
Journal:  J Liq Chromatogr Relat Technol       Date:  2011-01-01       Impact factor: 1.312

2.  Identification of chemical constituents and rat metabolites of Kangxianling granule by HPLC-Q-TOF-MS/MS.

Authors:  Lu Zheng; Lianxiang Fang; Haijian Cong; Ting Xiang; Ming Xue; Zhongqing Yao; Bin Wu; Wenhui Lin
Journal:  Biomed Chromatogr       Date:  2015-05-20       Impact factor: 1.902

3.  Systematic screening and characterization of multiple constituents in Guizhi Fuling capsule and metabolic profiling of bioactive components in rats using ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.

Authors:  Yu Zhang; Yezhe Cheng; Zhongbo Liu; Liqin Ding; Tianyi Qiu; Liwei Chai; Feng Qiu; Zhenzhong Wang; Wei Xiao; Longshan Zhao; Xiaohui Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-07-15       Impact factor: 3.205

4.  Isolation, structural elucidation and in vitro hepatoprotective activity of flavonoids from Glycyrrhiza uralensis.

Authors:  Ming Cheng; Liqin Ding; Hongfeng Kan; Hongmin Zhang; Benke Jiang; Yingjie Sun; Shijie Cao; Wei Li; Kazuo Koike; Feng Qiu
Journal:  J Nat Med       Date:  2019-06-19       Impact factor: 2.343

5.  Qualitative and quantitative analysis of the chemical constituents in Mahuang-Fuzi-Xixin decoction based on high performance liquid chromatography combined with time-of-flight mass spectrometry and triple quadrupole mass spectrometers.

Authors:  Qihui Sun; Hongjie Cao; Yanyan Zhou; Xu Wang; Haiqiang Jiang; Lili Gong; Yong Yang; Rong Rong
Journal:  Biomed Chromatogr       Date:  2016-07-05       Impact factor: 1.902

6.  Quality transitivity and traceability system of herbal medicine products based on quality markers.

Authors:  Changxiao Liu; De-An Guo; Liang Liu
Journal:  Phytomedicine       Date:  2018-03-06       Impact factor: 5.340

7.  Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.

Authors:  Jian Chen; Yong-Kui Wang; Yuan Gao; Ling-San Hu; Jiang-Wei Yang; Jian-Ru Wang; Wen-Jie Sun; Zhi-Qiang Liang; Ye-Min Cao; Yong-Bing Cao
Journal:  Biomed Pharmacother       Date:  2020-05-25       Impact factor: 6.529

8.  Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.

Authors:  Feng Zhang; Jian Huang; Wei Liu; Chao-Ran Wang; Yan-Fang Liu; Dong-Zhu Tu; Xin-Miao Liang; Ling Yang; Wei-Dong Zhang; Hong-Zhuan Chen; Guang-Bo Ge
Journal:  Food Chem Toxicol       Date:  2021-01-19       Impact factor: 6.023

9.  Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.

Authors:  Nannan Shi; Bin Liu; Ning Liang; Yan Ma; Youwen Ge; Honggang Yi; Hongmei Wo; Heng Gu; Yuan Kuang; Shaowen Tang; Yang Zhao; Lin Tong; Sihong Liu; Chen Zhao; Renbo Chen; Weiguo Bai; Yipin Fan; Zhan Shi; Li Li; Jia Liu; Hao Gu; Yingjie Zhi; Zhifei Wang; Yuanyuan Li; Huizhen Li; Jingya Wang; Liwen Jiao; Yaxin Tian; Yibai Xiong; Ruili Huo; Xiaohui Zhang; Jiangfeng Bai; Hong Chen; Liying Chen; Qiao Feng; Tuanmao Guo; Yong Hou; Guifen Hu; Xiaomei Hu; Yunhong Hu; Jin Huang; Qiuhua Huang; Shaozhen Huang; Liang Ji; Haihao Jin; Xiao Lei; Chunyan Li; Guihui Wu; Jike Li; Minqing Li; Quntang Li; Xianyong Li; Hongde Liu; Jinping Liu; Zhang Liu; Yuting Ma; Ya Mao; Liufen Mo; Hui Na; Jingwei Wang; Fangli Song; Sheng Sun; Dongting Wang; Mingxuan Wang; Xiaoyan Wang; Yinzhen Wang; Yudong Wang; Wei Wu; Lanping Wu; Yanhua Xiao; Haijun Xie; Hongming Xu; Shoufang Xu; Ruixia Xue; Chun Yang; Kaijun Yang; Puye Yang; Shengli Yuan; Gongqi Zhang; Jinbo Zhang; Linsong Zhang; Shusen Zhao; Wanying Zhao; Kai Zheng; Yingchun Zhou; Junteng Zhu; Tianqing Zhu; Guangxi Li; Wei Wang; Huamin Zhang; Yanping Wang; Yongyan Wang
Journal:  Pharmacol Res       Date:  2020-11-09       Impact factor: 7.658

10.  Identification and Comparison of Constituents of Aurantii Fructus and Aurantii Fructus Immaturus by UFLC-DAD-Triple TOF-MS/MS.

Authors:  Yang Bai; Yuying Zheng; Wenjing Pang; Wei Peng; Hao Wu; Hongliang Yao; Panlin Li; Wen Deng; Jinle Cheng; Weiwei Su
Journal:  Molecules       Date:  2018-03-30       Impact factor: 4.411

View more
  1 in total

1.  Integrating UPLC-HR-MS/MS, Network Pharmacology, and Experimental Validation to Uncover the Mechanisms of Jin'gan Capsules against Breast Cancer.

Authors:  Jianfei Qiu; Zhiyin Zhang; Anling Hu; Peng Zhao; Xuenai Wei; Hui Song; Jue Yang; Yanmei Li
Journal:  ACS Omega       Date:  2022-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.